Previous studies had already shown that Myc was a key protein in tumour development and had established how to inhibit…
Researchers at the Vall d’Hebron Institute of Oncology (VHIO) and University of North Carolina have conducted a study on gene…
Researchers at the Vall d’Hebron Institute of Oncology (VHIO) and University of North Carolina have conducted a study on gene…
The European Research Council (ERC) has awarded Joan Seoane, Director of Translational Research at the Vall d’Hebron Institute of Oncology…
• The new study published in Cancer Discovery, the flagship journal of the American Association of Cancer Research (AACR), involving…
World Cancer Day is the singular initiative under which UICC (Union for International Cancer Control), its members partners, supporters and…
Ø The study carried out with the support of the Spanish Association Against Cancer (AECC), indicates that senescence, or the…
ØThe study conducted by the Vall d’Hebron Institute of Oncology (VHIO) in conjunction with the GEICAM cooperative group and other American and Canadian researchers has led to a change in the definition of hormone-sensitive breast tumours
The Worldwide Innovative Network (WIN) in personalized cancer medicine consortium, of which the Vall d´Hebron Institute of Oncology (VHIO) is…
Li-Kuo Su, Editor-in-Chief of Cancer Cell will join us at the Hotel Alimara, Monday 14 January 2013, 09:00 – 10:15, …
Established in 2010, this year´s International Prize for Breast Cancer Research has been awarded to Aleix Prat at the 8th Advanced International Breast Cancer Course, 15 – 17 November, Padua Italy, by Pier Franco Conte and Gabriel N. Hortobagyi in recognition of his work using gene expression profiling to better classify tumors and thus achieve a better understanding of the disease.
The Worldwide Innovative Network (WIN) in personalized cancer medicine consortium, of which the Vall d´Hebron Institute of Oncology (VHIO) is…
